The clinical outcomes of adjuvant gemcitabine plus S-1 in resected pancreatic cancer: a single-center retrospective study

Abstract Background Adjuvant chemotherapy is the standard form of care for resected pancreatic cancer (PC) patients. Its treatment regimens include monotherapy with gemcitabine or S-1 and combination therapy with gemcitabine plus capecitabine or modified FOLFIRINOX (fluorouracil, oxaliplatin, irinot...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kuan-Yu Tseng, Yi-Ju Chen, Chiann-Yi Hsu, Yu-Hsuan Shih, Hsin-Chen Lin
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-07-01
Serie:	BMC Cancer
Soggetti:	Adjuvant chemotherapy Pancreatic cancer Gemcitabine plus S-1 Disease-free survival Overall survival
Accesso online:	https://doi.org/10.1186/s12885-025-14617-8
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!